RNAM vs. BSX

Last updated Jun 4, 2026

RNAM (Avidity Biosciences, Inc.) and BSX (Boston Scientific Corporation) are both stocks. Both are in the Healthcare sector — RNAM in Biotechnology, BSX in Medical Devices.

Performance

RNAM vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avidity Biosciences, Inc. (RNAM) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RNAM

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BSX

• 1D: 0.02%
• 1M: -16.11%
• YTD: -49.98%
• 6M: -51.62%
• 1Y: -53.74%
• 3Y*: -2.73%
• 5Y*: 2.56%
• 10Y*: 7.66%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RNAM vs. BSX - Yearly Performance Comparison

	2026 (YTD)
RNAM Avidity Biosciences, Inc.	0.00%
BSX Boston Scientific Corporation	-37.04%

Fundamentals

Market Cap RNAM : $10.87B BSX : $71.30B
EPS RNAM : -$4.93 BSX : $2.38
PS Ratio RNAM : 539.42 BSX : 3.46
PB Ratio RNAM : 6.44 BSX : 2.76
Total Revenue (TTM) RNAM : $18.76M BSX : $20.62B
Gross Profit (TTM) RNAM : $14.60M BSX : $14.52B
EBITDA (TTM) RNAM : -$741.79M BSX : $4.76B

Return for Risk

RNAM vs. BSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX

BSX Risk / Return Rank: 1
BSX Sharpe Ratio Rank: 0
BSX Sortino Ratio Rank: 1
BSX Omega Ratio Rank: 1
BSX Calmar Ratio Rank: 3
BSX Martin Ratio Rank: 0

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RNAM vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avidity Biosciences, Inc. (RNAM) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RNAM	BSX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-1.56	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.10	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.28	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.19	—

Drawdowns

Drawdown Indicators

	RNAM	BSX	Difference
Max Drawdown Largest peak-to-trough decline	—	-89.15%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-55.91%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-55.91%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-55.91%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-55.91%	—
Current Drawdown Current decline from peak	—	-55.90%	—
Average Drawdown Average peak-to-trough decline	—	-38.75%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	24.56%	—

Volatility

Volatility by Period

	RNAM	BSX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	16.20%	—
Volatility (6M) Calculated over the trailing 6-month period	—	32.82%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	34.63%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	25.66%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	27.29%	—

Dividends

RNAM vs. BSX - Dividend Comparison

Neither RNAM nor BSX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials